» Articles » PMID: 6136000

Analysis of Bradykinin Receptor Mediating Relaxation of Cat Cerebral Arteries in Vivo and in Vitro

Overview
Specialty Pharmacology
Date 1983 Jun 1
PMID 6136000
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Bradykinin (BK), methionyl-lysyl-BK (M-L-BK) and des-Arg9-BK produced, in decreasing potency, dose-related dilatations of the superficial pial arteries of the cat in vivo. The competitive, specific B1-receptor antagonist, des-Arg9-Leu8-BK was ineffective against BK-induced dilatations in this in vivo model. On the cat middle cerebral artery in vitro (but not the basilar artery), under resting tension and when contracted with 5-hydroxytryptamine (5-HT) or KCl, concentration related relaxations were produced by BK, M-L-BK, and des-Arg9-BK, this being the order of relative potency of the three kinins. There was no increase in the sensitivity of either the middle cerebral or the basilar artery in vitro under resting tension or when contracted with 5-HT or KCl to BK or des-Arg9-BK, concentration effect curves to which were produced at 2 h intervals over an 8 h period. The B1-receptor antagonist des-Arg9-Leu8-BK was ineffective against relaxations to BK or des-Arg9-BK of the middle cerebral artery under resting tension or when contracted with 5-HT. The receptor mediating dilatation of the superficial pial arteries of the cat in vivo and relaxation of the middle cerebral artery in vitro to kinins is of the B2-type. The cat basilar artery in vitro is relatively insensitive to the action of kinins and this is possibly due to an absence of receptors for kinins on this tissue.

Citing Articles

Enhancement of bradykinin-induced relaxation by focal brain ischemia in the rat middle cerebral artery: Receptor expression upregulation and activation of multiple pathways.

Li Y, Lapina N, Weinzierl N, Schilling L PLoS One. 2018; 13(6):e0198553.

PMID: 29912902 PMC: 6005516. DOI: 10.1371/journal.pone.0198553.


The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice.

Trabold R, Eros C, Zweckberger K, Relton J, Beck H, Nussberger J J Cereb Blood Flow Metab. 2009; 30(1):130-9.

PMID: 19773800 PMC: 2949094. DOI: 10.1038/jcbfm.2009.196.


LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.

Ding-Zhou L, Margaill I, Palmier B, Pruneau D, Plotkine M, Marchand-Verrecchia C Br J Pharmacol. 2003; 139(8):1539-47.

PMID: 12922942 PMC: 1573979. DOI: 10.1038/sj.bjp.0705385.


Stimulation of bradykinin B2-receptors on endothelial cells induces relaxation and contraction in porcine basilar artery in vitro.

Miyamoto A, Ishiguro S, Nishio A Br J Pharmacol. 1999; 128(1):241-7.

PMID: 10498858 PMC: 1571616. DOI: 10.1038/sj.bjp.0702783.


Kinin receptors and angiotensin converting enzyme in rabbits basilar arteries.

Whalley E, Fritz H, Geiger R Naunyn Schmiedebergs Arch Pharmacol. 1983; 324(4):296-301.

PMID: 6141533 DOI: 10.1007/BF00502627.


References
1.
Regoli D, MARCEAU F, Barabe J . De novo formation of vascular receptors for bradykinin. Can J Physiol Pharmacol. 1978; 56(4):674-7. DOI: 10.1139/y78-109. View

2.
MARCEAU F, Barabe J, St-Pierre S, Regoli D . Kinin receptors in experimental inflammation. Can J Physiol Pharmacol. 1980; 58(5):536-42. DOI: 10.1139/y80-088. View

3.
Toda N . Actions of bradykinin on isolated cerebral and peripheral arteries. Am J Physiol. 1977; 232(3):H267-74. DOI: 10.1152/ajpheart.1977.232.3.H267. View

4.
Brabe J, Drouin J, Regoli D, Park W . Receptors for bradykinin in intestinal and uterine smooth muscle. Can J Physiol Pharmacol. 1977; 55(6):1270-85. DOI: 10.1139/y77-173. View

5.
Wahl M, Kuschinsky W . Unimportance of perivascular H+ AND K+ activities for the adjustment of pial arterial diameter during changes of arterial blood pressure in cats. Pflugers Arch. 1979; 382(3):203-8. DOI: 10.1007/BF00583703. View